Robert Kramer, President and CEO at Emergent BioSolutions Inc. (EBS), sold 38,052 shares at $106.01 ($4.0M) on 2021-01-15, disclosed to the SEC on 2021-01-19.
Open-market sale of $4.0M EBS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.01 | 19,026 | $2.0M | 50.0% |
| 2 | $106.01 | 19,026 | $2.0M | 50.0% |
| Total | $106.01 avg | 38,052 | $4.0M | 100% |
| Filing → |
| EBS | SELL | 2016-04-08 | $847K | — | Filing → |
| EBS | SELL | 2016-04-05 | $804K | — | Filing → |
| EBS | SELL | 2016-04-05 | $3.0M | — | Filing → |